Grant Applicant

The exact set depends on the call, but several items recur in R&D projects. First, documents confirming your right to the technology the project is built on: assignment agreements, licenses, and declarations that third parties have no claims – the funding institution wants to be sure the applicant can lawfully carry out the work and implement its results. Second, evidence of the solution's novelty and innovativeness: a prior art search report, filed patent applications and, in some calls, an innovation opinion. Third, a freedom-to-operate (FTO) analysis (a prior art search), confirming that the planned product will not conflict with third-party exclusive rights. Consortium projects also require a consortium agreement with a clear division of rights to the results. Prepare these documents before the call opens – some of them (searches, analyses, filings) take weeks, and call deadlines are rigid.

Yes, in several ways. The innovativeness of the solution is one of the main evaluation criteria, and a filed patent application is strong, objective evidence of novelty for the evaluators – stronger than the applicant's own declarations, because the solution has been made concrete and put through an official procedure. An application with a favorable search report works even better, as it makes it more likely that protection will actually be granted. IP protection also strengthens the assessment of implementation potential: a competitive edge secured by an exclusive right lends credibility to the revenue forecasts on which the project's financial model rests. Finally, some programs directly reward or fund obtaining protection as part of the project. Bear in mind, though, that filing alone does not guarantee a patent will be granted – the experts evaluating applications know this, so the quality of the application matters.

A freedom-to-operate (FTO) analysis answers one question: can the planned product or technology be used without infringing exclusive rights in force in the target markets? It examines the claims of granted patents as well as pending applications. In a grant project it carries special weight: the goal of an R&D project is to implement the results, and an implementation blocked by someone else's patent means the project misses its indicators – up to and including a financial correction or repayment of the funding. That is why funding institutions require this analysis or assess it as part of project feasibility; for the applicant, it is insurance on their own investment, as their own contribution is usually at least half of the budget. Carry out the analysis before submitting the application and update it whenever the product concept changes in the course of the work – new competitor applications are published all the time. In grant projects, this analysis often goes by the general name "prior art search".

Yes, through several channels. In the SMART Path (Ścieżka SMART) under the FENG program (European Funds for a Modern Economy), industrial property protection is a separate project module: funding of up to 50% covers the costs of obtaining protection – including attorney services, official fees, and translations – and, uniquely, the costs of defending your rights in the event of infringement. In the EU SME Fund, the patent voucher covers not only official fees but also 50% of the legal costs of preparing and filing a European application. Independently of grants, the costs of obtaining and maintaining a patent, a utility model protection right, or an industrial design registration count as eligible costs of the R&D tax relief for SMEs, which means an additional tax deduction. One condition common to the grants: costs must be incurred in line with the program's schedule – usually after the voucher application has been filed or within the project's eligibility period, never retroactively.

The application itself does not usually destroy novelty – competition documentation is not publicly available, and the evaluating experts and institution staff are generally bound by confidentiality. The risk arises around the application: brief descriptions of funded projects are published; the grant agreement imposes information and publicity obligations; and on top of that come panel presentations, trade fairs, and demonstrations during the project. There is no grace period in Europe – any public disclosure before the filing date irreversibly closes the road to a patent. The safe sequence: patent application first, before the grant application is submitted – and in any case before results are published or promotion begins. If filing is not yet possible, describe the solution in the application in functional terms – what it achieves and with what parameters – without revealing the essence of the design you plan to claim. In projects with a research partner, you additionally need a clause holding back publications until the filing is made.

They are documents with different functions that complement each other. A prior art search is an analytical document: a patent attorney identifies in patent databases the patented solutions closest to yours, compares them with it, and assesses whether the planned solution can be implemented without the risk of infringing those rights. It is an objective, documented basis for the decision to implement the project. An innovation opinion, on the other hand, is an expert assessment issued by an independent research institution, a university, or a scientific and technical association, confirming – for the purposes of a specific competition – that the technology is new or has been in use worldwide for no longer than a specified period; its format and required issuer follow from the rules of the given call. Put simply: the report shows that implementation is safe from a patent standpoint, while the opinion confirms innovativeness as defined by the competition criteria.

The starting rule: rights to the results of commissioned work do not automatically pass to the commissioning party in full – you need a contract. It should cover the transfer of economic rights with the fields of exploitation listed and consent to the exercise of derivative rights, the allocation of the right to obtain a patent for inventions created in the course of the work, delivery of complete documentation, and a confidentiality obligation with a ban on publishing the results until a filing is made. In grant projects this matters twice over: the beneficiary must hold the rights to the results in order to settle the project and carry out the implementation, and gaps in the chain of title come to light during audits. Subcontracting to research institutions requires particular care – university IP regulations overlap here with the market price requirement that follows from state aid rules. Sign the agreements with subcontractors before the work begins, not at handover.

Yes – in programs funding R&D work, including the SMART Path (Ścieżka SMART), implementing the results is an obligation of the beneficiary, and failure to do so by the deadline set in the grant agreement can result in a financial correction or repayment of the support. Implementation does not have to mean in-house production only: the accepted forms usually also include selling the rights to the results and licensing them out – and both routes require the results to be embodied in rights that can be traded: applications and patents, designs, copyright in software. Exclusive rights also strengthen in-house implementation, because they protect the edge on which the profitability assumed in the application rests. When commercializing through sale or license, keep the market price condition in mind – transferring the results of a publicly funded project below market value creates the risk of an unlawful state aid allegation.

These instruments work at different stages and stack well in sequence: the grant lowers the cost of developing the solution, the R&D tax relief additionally reduces the tax base by the eligible costs of the work (up to 200% of R&D staff salaries), and IP Box cuts the tax on income from commercializing qualified IP rights to 5%. Two points need attention, though. First, the R&D relief does not allow you to deduct costs that have been reimbursed in any form – the part covered by the grant cannot be used twice; what you can deduct is your own contribution. Second, the IP Box catalog is almost entirely limited to registrable rights: a patent, a utility model, an industrial design, copyright in a computer program – know-how and trade secrets cannot be used. The decision to file a patent application therefore has a tax dimension as well. A condition of using IP Box is keeping separate records of income and costs per right, from the very beginning – gaps in these records are the most common reason the relief is challenged.

Yes. The IP protection module in the SMART Path (Ścieżka SMART) is available only within a project with eligible costs of at least approx. EUR 750,000 – but for standalone filings there is a simpler route: the SME Fund run by the European Union Intellectual Property Office (EUIPO). In the 2026 edition it reimburses 90% of the initial IP Scan diagnostic (up to EUR 1,080), 75% of trademark and design application fees (up to EUR 700), and patent costs up to EUR 3,500, including half of the legal costs of preparing a European application. The mechanics are simple, but the order is absolute: first the voucher application, and only once the voucher is granted do you incur the costs – earlier expenses are not reimbursed. The pool works on a first-come, first-served basis and runs out during the year, so it is worth applying at the start of the call. The applicant can act through a representative – we will gladly check voucher availability and guide you through the procedure.